ZURICH, May 29 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent lower at 8,761 points on Tuesday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks:
A combination of Roche’s Tecentriq immunotherapy with chemotherapy helped people with a form of lung cancer live significantly longer than patients on chemotherapy alone, a late-stage trial cited by the Swiss drugmaker showed.
Swiss watch exports rise a nominal 13.8 percent year-on-year in April
* Sika AG details convertible bond allocation
* Private Equity Holding AG: decided to continue company’s distribution policy albeit at a lower level of CHF 2.00 per share; board member Hans Christoph Tanner will not be standing for re-election
* Burckhardt Compression Holding AG FY consolidated net income at CHF 29.0 mn, 10.6% less than in previous fiscal year
* Zehnder Group AG: optimises radiator production network in Europe
* Huegli Holding AG decides to file petition for de-listing of Hügli bearer shares
* SHL Telemedicine Ltd to record additional income of EUR 6.2 million in 2018 from 2016 contract in Germany
* Peach Property Group AG: issue of a hybrid warrant bond; issue volume of CHF 50m with a possibility to increase to a maximum of CHF 100m
* Ascom Holding AG: wins $800,000 U.S. order
Swiss trade suplus 2.29 billion Swiss francs in April (Reporting by Zurich newsroom)